Home › Funds › Frazier Life Sciences Management, L.P. › ALKS

Frazier Life Sciences Management, L.P. position in ALKS

ALKERMES PLC · Health Care

Frazier Life Sciences Management, L.P. reported holding 700,647 shares of ALKS (ALKERMES PLC) in its Q2 2026 13F filing — a position valued at US$36.7M, representing 0.80% of its reported portfolio and ranking #24 among its reported holdings. Frazier Life Sciences Management, L.P. has disclosed ALKS holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)700.65K sh
Reported value held$36.71M
Portfolio Weight0.80%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Frazier Life Sciences Management, L.P.'s ALKS position evolved

Frazier Life Sciences Management, L.P. first disclosed a stake in ALKS in Q3 2024 at 576,129 shares (US$16.1M). The position peaked in Q2 2026 at 700,647 shares, worth US$36.7M. Across 8 filings, Frazier Life Sciences Management, L.P. increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 700,647 shares valued at US$36.7M. Notable position changes include a 66% increase in Q2 2025 (shares rose 5% over the following quarter), a 30% trim in Q3 2025 (shares fell 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 576.13K $16.13M New
Q4 2024 601.13K $17.29M Add
Q1 2025 601.13K $19.85M Hold
Q2 2025 1.00M $28.63M Add
Q3 2025 700.65K $21.02M Reduce
Q4 2025 700.65K $19.60M Hold
Q1 2026 700.65K $24.77M Hold
Q2 2026 700.65K $36.71M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALKS and 13F data

ALKS (ALKERMES PLC) is a Health Care company. 43 other funds we track also report a position in ALKS — the largest reported positions include BAKER BROS. ADVISORS LP (US$524.6M), Renaissance Technologies (US$338.5M), Deep Track Capital, LP (US$209.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALKS

All ALKS fund holders →

FAQ

How long has Frazier Life Sciences Management, L.P. held ALKS?

Frazier Life Sciences Management, L.P. has disclosed ALKS holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Frazier Life Sciences Management, L.P.'s current position in ALKS?

As of Q2 2026, Frazier Life Sciences Management, L.P. holds 700.65K shares of ALKS (ALKERMES PLC), valued at $36.71M, representing 0.80% of its reported portfolio and ranking #24.

Has Frazier Life Sciences Management, L.P. been buying or selling ALKS?

In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. held unchanged its position in ALKS. The position peaked in Q2 2026 at 700.65K shares.

Which other funds hold ALKS?

Other major institutional holders of ALKS include BAKER BROS. ADVISORS LP, Renaissance Technologies, Deep Track Capital, LP, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.